ArticlePloS one2025
Estimating multiplicity of infection, haplotype frequencies, and linkage disequilibria from multi-allelic markers for molecular disease surveillance.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular surveillance of multiplicity of infection, haplotype frequencies, and prevalence in infectious diseases.PLoS computational biology · 2026Article
- Regional variation in sulfadoxine-pyrimethamine resistance genotypes and haplotypes of Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Western Kenya.Malaria journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMolecular/genetic methods are becoming increasingly important for surveillance of diseases like malaria. Such methods allow monitoring routes of disease transmission or the origin and spread of variants associated with drug resistance. A confounding factor in molecular disease surveillance is the presence of multiple distinct variants in the same infection (multiplicity of infection - MOI), which leads to ambiguity when reconstructing which pathogenic variants are present in an infection. Heuristic approaches often ignore ambiguous infections, which leads to biased results.
methodsTo avoid bias, we introduce a statistical framework to estimate haplotype frequencies alongside MOI from a pair of multi-allelic molecular markers. Estimates are based on maximum likelihood using the expectation-maximization (EM)-algorithm. The estimates can be used as plug-ins to construct pairwise linkage disequilibrium (LD) maps. The finite-sample properties of the proposed method are studied by systematic numerical simulations. These reveal that the EM-algorithm is a numerically stable method in our case and that the proposed method is accurate (little bias) and precise (small variance) for a reasonable sample size. In fact, the results suggest that the estimator is asymptotically unbiased. Furthermore, the method is appropriate to estimate LD (by [Formula: see text], [Formula: see text], [Formula: see text], or conditional asymmetric LD). Furthermore, as an illustration, we apply the new method to a previously published dataset from Cameroon concerning sulfadoxine-pyrimethamine (SP) resistance. The results are in accordance with the SP drug pressure at the time and the observed spread of resistance in the country, yielding further evidence for the adequacy of the proposed method.
conclusionThe proposed method can be readily applied in practice for malaria disease surveillance as a replacement for heuristic methods. The first benefit is its ability to estimate MOI, which scales with transmission intensities, and, in a temporal context, can be used to evaluate the effectiveness of disease control measures. MOI is best estimated from molecular markers that are not under selection (neutral markers) and exhibit sufficient genetic variation. The second advantage is that it can estimate pairwise LD without deflating sample size as in heuristic methods, thereby limiting uncertainty in the estimates. This is particularly useful when deriving LD maps from data with many ambiguous observations due to MOI. Importantly, the method per se is not restricted to malaria, but applicable to any disease with a similar transmission pattern. The method and several extensions are implemented in an easy-to-use R script.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.